Article

Avery A. J., Savelyich B. S., Sheikh A., et al. Identifying and establishing consensus on the most important safety features of GP computer systems: e-Delphi study

Primary Care Information Services (PRIMIS), Division of Primary Care, University of Nottingham, The Medical School Queen's Medical Centre, Nottingham, UK.
Informatics in primary care 02/2005; 13(1):3-12. DOI: 10.14236/jhi.v13i1.575
Source: PubMed

ABSTRACT Our objective was to identify and establish consensus on the most important safety features of GP computer systems, with a particular emphasis on medicines management. We used a two-round electronic Delphi survey, completed by a 21-member multidisciplinary expert panel, all from the UK. The main outcome measure was percentage agreement of the panel members on the importance of the presence of a number of different safety features (presented as clinical statements) on GP computer systems. We found 90% or greater agreement on the importance of 32 (58%) statements. These statements, indicating issues considered to be of considerable importance (rated as important or very important), related to: computerised alerts; the need to avoid spurious alerts; making it difficult to override critical alerts; having audit trails of such overrides; support for safe repeat prescribing; effective computer-user interface; importance of call and recall management; and the need to be able to run safety reports. The high level of agreement among the expert panel members indicates clear themes and priorities that need to be addressed in any further improvement of safety features in primary care computing systems.

Download full-text

Full-text

Available from: Aziz Sheikh, Aug 21, 2015
0 Followers
 · 
224 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The quality framework developed by The Royal Australian College of General Practitioners is described by Booth in this issue of Australian Family Physician. This article applies the framework to the 'knowledge and information' domain. This article draws on selected examples of immediate relevance to Australian general practitioners to demonstrate the value of such a framework. The framework provides a mechanism for assessing policy and implementation initiatives in an Australian context that takes account of the realities of clinical practice. Management, implementation of guidelines, immunisation, electronic prescribing, and decision support are considered using descriptive or analytical approaches.
    Australian family physician 36(1-2):28-30. · 0.67 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: First purified 11 years ago from clam ganglia, FMRFamide (Phe-Met-Arg-Phe-NH2) was quickly demonstrated to be cardioactive in several molluscan species. Subsequent discovery that FMRFamide, or FMRFamide-related peptides (FaRPs), were present in mammalian central nervous system and gastrointestinal tract prompted investigations into the effect of FMRFamide on mammals. FMRFamide has now been shown to be cardioexcitatory in mammals, to inhibit morphine-induced antinociception, and to block morphine-, defeat-, and deprivation-induced feeding. It also inhibits colonic propulsive motility, induces behavioral effects when administered intrathecally, and has been reported to have amnesic effects in rodents. A proposal has arisen that a FMRFamide-like substance is an endogenous opioid antagonist and has stimulated a search for such a substance. However, FMRFamide has only weak affinity for opioid receptors and not all the actions of FMRFamide appear to be explained by actions at opioid receptors. Alternative mechanisms have been proposed which suggest that FMRFamide acts as a neuromodulator.
    Peptides 07/1988; 9(4):915-22. DOI:10.1016/0196-9781(88)90141-6 · 2.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: T he first article of this series demonstrated that preventable drug--related morbidity (PD-RM) in primary care remains an un-der-recognized public health pro-blem 1 . The precise prevalence of PD-RM from drug usage in primary care Nota do Editor: O Artigo dos mesmos autores intitulado Considerations on preventable drug-rela-ted morbidity in Primary Care Part I – Im-pact of preventable drug-related morbidi-ty, publicado na Rev Port Clin Geral 2005; 21:269-79 foi classificado por engano na secção Estudos Originais. Na realidade trata-se de um Artigo de Revisão. Pelo erro, da responsabilidade da redacção, pedimos desculpa aos autores e aos leitores. ABSTRACT Objective: To review the literature on strategies to reduce the risk of preventable drug-related morbidities in primary care. Methods: We searched nine electronic databases, bibliographies of papers, two authoritative internet sites and used personal contacts to identify literature on strategies to improve the safety and the quality of medicines usage in primary care. Results: The combined search strategy yielded 96 potentially relevant references. Those which met our inclusion criteria were divided into reviews and original articles; if available the former were used in the present work. References were further grouped into four not mu-tually exclusive categories, according to the stage of the medication-use process they were directed at: prescribing, dispensing, adminis-tration/compliance and monitoring stages. Five main strategies emerged to improve the safety and quality of the medication-use process in primary care: educational strategies for practitioners, educational strategies for patients, behavioural strategies for patients, computeri-sation and revision of professional roles. These strategies may be applicable to more than one stage of the medication-use process and comprise a large number of possible interventions, such as academic detailing and workshops, the use of memorandums and information technology to support medicine-taking, computerising patient data, employing informatics to support practitioners' decision-making and auto-mated signalling of risk events. Conclusion: Reducing preventable drug-related morbidities in primary care is likely to require the adoption of multiple strategies at diffe-rent stages of the medication-use process, targeting simultaneously not only people, but also procedures, and the organisation. The imple-mentation of interventions should ideally be guided by evidence on their value. Educational efforts directed to health care professionals and behavioural strategies to enhance patient compliance have been extensively studied, while the use of informatics and the inclusion of pharmacists in therapeutic management need further research to evaluate their benefit.
Show more